About Oxford Cardiovascular Science

Researchers across Oxford are working together at the forefront of cardiovascular science, with the overall goal of translating discoveries from the laboratory though to clinical practice.  Our researchers will apply new cross cutting technologies to develop cardiovascular imaging and phenotyping, drug development, cardiac computer modelling and stem cell & gene therapy.

We have outstanding experience in conducting clinical trials and epidemiological studies as well as state-of-the-art basic science and clinical reserach facilities. We are particularly proud of our ability to bring together molecular, epidemiological and physiological research to understand cardiac and vascular disease right from the molecular level all the way up to the wider population.

The British Heart Foundation is a key sponsor of cardiovascular research in Oxford and their two research centres offer scientists across the city fantastic opportunities for research & training, supporting the current and next generation of leaders in Cardiovascular Science.

BHF Centre of Research Excellence


The aim of the BHF CRE in Oxford is to emerge as one of the leading cardiovascular centres worldwide. 

The BHF CRE in Oxford brings together over 60 world leading clinical and laboratory researchers, based in Departments and Centres across the University of Oxford. Their research spans diverse areas and covers the translational research spectrum, from basic to clinical research.

BHF Centre of Regenerative Medicine


The ultimate goal of the BHF CRM in Oxford is to understand how the heart might be taught to repair itself after the damage of a heart attack.

The Oxbridge BHF CRM brings together 26 world leading basic and translational research groups (13 based in Oxford, 12 based in Cambridge, and 1 based in Bristol) merging significant expertise in cardiovascular repair and regeneration (Oxford), wound healing (Bristol), with a major focus on stem cells (ESCs and iPSCs) and genetics in the context of regeneration (Cambridge).

News & Events

Drugs from bugs

Posted 23/02/2017

LAB282, the £13m drug discovery partnership for Oxford University, has made its first wave of awards, backing projects targeting cardiovascular and infectious diseases. Launched last year as a partnership between the University, Evotec and Oxford Sciences Innovation, LAB282 aids the rapid ...

Congratulations to Dr Charis Antoniades!

Congratulations to Dr Charis Antoniades!

Posted 02/09/2016

  A huge congratulations to Dr Antoniades who has been awarded the Outstanding Achievement award of the European Society of Cardiology. The Award is given each year by the Council of Basic Cardiovascular Science to a basic scientist for their overall contribution to cardiovascular science. This ...

Dr Oliver Rider awarded a BHF Intermediate Clinical Research Fellowship

Posted 02/09/2016

Many congratulations to Dr Oliver Rider, who has been awarded a BHF Intermediate Clinical Research Fellowship (£789K over 4 years), following on from 2 years as an Oxford BHF CRE Transition Research Fellow. Oliver will carry out his research “Comparing the effects of bariatric surgery on the ...

Dr. Rohan Wijesurendra - Winner of ESC Congress 2016 Young Investigator Award (Clinical Science)

Posted 02/09/2016

Dr. Rohan Wijesurendra - Clinical Lecturer in Cardiovascular Medicine - is the winner of the Young Investigator Award in Clinical Science at the European Society Congress (ESC) 2016, which took place in Rome, Italy. He won this competitive title, along with a prize of 2000 €, based on his work ...

Dr Ayman Al Haj Zen wins first prize at the Imperial College BHF CRE annual symposium

Dr Ayman Al Haj Zen wins first prize at the Imperial College BHF CRE annual symposium

Posted 21/07/2016

Congratulations to Ayman Al Haj Zen, who took first prize for his poster at the Imperial College BHF CRE annual symposium on “Cardiovascular target identification and drug discovery” which was held in London on Monday 18th June.  Ayman’s poster title was “The retinoid agonist Tazarotene promotes ...

See the news archive